| Name | Title | Contact Details |
|---|
CTi’s technologies is a publicly Traded on OTC markets as CVAT.(OTCQB: CVAT; Berlin: WTC). Cavitation Technologies, Inc. (CTi) owns and markets patented and patent-pending processes and devices developed to reduce processing costs, improve yield an...
Firsthand is a career-building platform that helps you navigate your career journey. From mentors to mock interviews to resume feedback, we support your goals.
Since the Company's inception in 1999, scientists and engineers at AutoGenomics have endeavored to create automated technologies that simplify the complex test processes inherent in genetic analysis within a format that is user friendly and increases productivity in the clinical laboratory. The INFINITI® system is designed specifically for processing AutoGenomics' unique proprietary BioFilmChip® microarrays that can be multiplexed and configured with hundreds of biomarkers to assess disease signatures from a single sample specimen. The INFINITI system provides clinical laboratories with significant improvements in laboratory productivity, workflow and cost per reportable result. Corporate Overview